Accellacare of Knoxville

Knoxville, Tennessee 37938

2 studies enrolling now · 6 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, COVID-19, Chronic Idiopathic Constipation (CIC), Obesity, Obesity or Overweight, Overweight, Overweight With One Weight Related Comorbidity, Respiratory Syncytial Virus Infections, SARS-CoV2

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults — Recruiting now
• A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity — Completed
• A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection — Running, not enrolling
• A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity — Running, not enrolling
• MVA-BN-RSV Vaccine Trial — Stopped early